Cy-Tb - The next gen test for latent TB DETECTION

Diagnose. Detect. Defeat.

~ 25%

of the estimated world population is infected with latent TB

5-10%

of latent TB individuals get active TB disease in their lifetime

~40%

of Indians live with latent TB

The Next Gen Test to Detect Latent TB infection

Detecting latent TB before it becomes active TB is the cornerstone of the TB elimination strategy. Cy-Tb is the next-generation test for latent TB detection. Manufactured by the Serum Institute of India, Cy-Tb combines the accuracy of IGRA with the ease of Tuberculin Skin Tests (TSTs). With robust data from clinical trials across three continents, the test has been highly effective across population groups. It has been validated by ICMR in India

Kit Introduction

Cy-Tb™

Detecting latent Tb before it becomes active Tb is the cornerstone of Tb elimination strategy. Cy-Tb is the third generation test for latent Tb detection. Developed by Serum Institute of India, Cy-Tb combines the accuracy of IGRA with the ease of TSTs. With robust data from clinical trials in 3 continents, the test has proven tobehighly effective a cross population groups.

Product benefits of Cy-Tb for latent TB Detection

Unaffected by BCG Vaccination Status

Cy-Tb overcomes the problem of false positive in the previously BCG vaccinated Individuals

No Sample Handling

Unlike IGRA, no need for sample collection, transportation and testing in a controlled lab environment

Easy to Administer

Administered using widely popular Mantoux technique

Special Population Consideration Suitable for

• HIV-infected individual • Paediatric population

Point of Care Test

Performed in the field without any lab facility

Convenient 10 Doses per Vial

Multidose vial is excellent for programmatic implementation

Smart Patch to Track and Trace

Patented smart patch to help track and trace the patients along with administration guidance
(To be launched soon)

Companion AI-driven App

End-to-end App, from patient registration to interpretation of results in a consistent manner
(To be launched soon)

Product Details

Summary of Clinical Validation

Cy-Tb test results correlate with exposure to M. tuberculosis
Cy-Tb and QFT have similar positivity rates
Safety profile of Cy-Tb is comparable to PPD
Excellent diagnostic performance in children, adolescents & adults
One single cut-off independent of endemic setting and disease/vaccination status
Cy-Tb delivers IGRA like performance in the field-friendly skin test format using a universal 5 mm cut off

Cy-Tb - The next gen test for latent TB DETECTION

Diagnose. Detect. Defeat.

~ 25%

5-10%

~40%

The Next Gen Test to Detect Latent TB infection

Kit Introduction

Cy-Tb™

Product benefits of Cy-Tb for latent TB Detection

Product Details

Composition

Form

Indications

Dosage

Method of Administration

Interpretation

Storage Requirements

Universal administration technique

Summary of Clinical Validation